BAXALTA
Baxalta Incorporated (Baxalta) is a biopharmaceutical company with a portfolio of differentiated therapies that seek to address medical needs across various disease areas, including hemophilia, immunology and oncology
BAXALTA
Industry:
Biotechnology Pharmaceutical
Founded:
2014-01-01
Address:
Illinois City, Illinois, United States
Country:
United States
Website Url:
http://www.baxalta.com
Total Employee:
10001+
Status:
Active
Contact:
(224)940-2000
Email Addresses:
[email protected]
Technology used in webpage:
SPF Domain Not Resolving SSL By Default Apple Mobile Web Clips Icon Amazon Content Delivery Network Mobile Non Scaleable Content DMARC Microsoft Exchange Online Office 365 Mail
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-07-23 | ONCASPAR (pegaspargase) | ONCASPAR (pegaspargase) acquired by Baxalta | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-06-08 | Precision BioSciences | Baxalta investment in Series B - Precision BioSciences | 110 M USD |
| 2016-05-07 | OncoResponse | Baxalta investment in Series A - OncoResponse | 12.5 M USD |
Official Site Inspections
http://www.baxalta.com
- Host name: afe41c95a9e82f02c.awsglobalaccelerator.com
- IP address: 13.248.133.121
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Baxalta"
Baxalta - Wikipedia
Baxalta (Bax from the name of its former parent company; alta a Latin adjective meaning 'high' or 'profound' ) is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division. The company began its operation with a revenue of $6 billion, and is now a subsidiary of Takeda Pharmaceutical Company. See details»
Baxalta
Untitled DocumentSee details»
Baxalta Pharmaceutical Company
Baxalta Pharmaceutical Company announced its 9 month financial results and held a presentation for analysts on Thursday 28 October 2021. To watch the recording of the presentation please follow the link below.See details»
Leading Innovation in Pharmaceuticals
A global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs.See details»
Baxalta - Crunchbase Company Profile & Funding
Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing.See details»
Organization | Baxalta - Purdue University
Baxalta Report issue Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4 Founded: Deerfield IL United States (1931) Status: Acquired by Shire (2016) → now Takeda (2018)See details»
Baxalta 2025 Company Profile: Valuation, Investors, …
Information on acquisition, funding, investors, and executives for Baxalta. Use the PitchBook Platform to explore the full profile.See details»
PowerPoint Presentation
Meeting Objectives Introduce Baxalta Incorporated, our new culture and leadershipSee details»
Baxalta Company Profile - Office Locations, Competitors ... - Craft
See insights on Baxalta including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
About Us - Baxalta Pharmaceutical Company
Baxalta Pharmaceutical Company is a global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment …See details»
Shire completes combination with Baxalta creating the …
Jun 3, 2016 Shire completes combination with Baxalta creating the global leader in rare diseases and highly specialized conditionsThrough the combination, Shire expects to deliver double-digit compound annual top-line growth, with over …See details»
Baxter Announces Baxalta as the Name of the New Global ...
Sep 10, 2014 Baxalta will have approximately $6 billion in global revenues and be a leading provider of therapeutic treatments that save, sustain and improve the lives of people with rare …See details»
BAXALTA US INC. Company Profile | Van Nuys, CA | Competitors ...
Find company research, competitor information, contact details & financial data for BAXALTA US INC. of Van Nuys, CA. Get the latest business insights from Dun & Bradstreet.See details»
How Baxter’s Biosciences Spin-off into Baxalta Improved Its …
Mar 19, 2016 On July 1, 2015, Baxter separated its Biosciences division into a new entity named Baxalta in an effort to divest risky segments and streamline operations.See details»
Baxalta, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Baxalta, Inc. with its drug pipeline, therapeutic area, technology platform, 113 clinical trials, 117 news, and 52 literature, Disease Domain:Hemic and Lymphatic Diseases, Infectious …See details»
Baxalta - Pivot Design
Created when Baxter International spun off its biopharmaceutical division, Baxalta burst to life in 2015 with a portfolio of drugs for hematology, oncology, and immunology. As the $6 billion …See details»
Baxalta - Funding, Financials, Valuation & Investors - Crunchbase
Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing.See details»
Baxalta: Building Trust with Patients - Technology and Operations ...
Dec 8, 2015 The global biopharmaceutical company Baxalta is an example of a firm that has effectively integrated its business and operating models. With sales of $16.7B in 2014, …See details»
Corporate governance | Baxalta Pharmaceutical Company
Baxalta Pharmaceutical Company recognizes the importance of clear and transparent regulations in respect of corporate governance for the confidence of investors in its policies and strategy.See details»
Baxalta Incorporated Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Baxalta Incorporated of Bannockburn, IL. Get the latest business insights from Dun & Bradstreet.See details»